146 related articles for article (PubMed ID: 19729283)
1. Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remission.
Bobes J; Ciudad A; Alvarez E; San L; Polavieja P; Gilaberte I
Schizophr Res; 2009 Nov; 115(1):58-66. PubMed ID: 19729283
[TBL] [Abstract][Full Text] [Related]
2. Remission in schizophrenia: results from a 1-year follow-up observational study.
Ciudad A; Alvarez E; Bobes J; San L; Polavieja P; Gilaberte I
Schizophr Res; 2009 Mar; 108(1-3):214-22. PubMed ID: 19168329
[TBL] [Abstract][Full Text] [Related]
3. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.
Novick D; Haro JM; Suarez D; Vieta E; Naber D
Schizophr Res; 2009 Mar; 108(1-3):223-30. PubMed ID: 19070991
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
5. The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study.
Helldin L; Kane JM; Hjärthag F; Norlander T
Schizophr Res; 2009 Nov; 115(1):67-73. PubMed ID: 19666215
[TBL] [Abstract][Full Text] [Related]
6. One-year functional outcomes of naturalistically treated patients with schizophrenia.
Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study.
San L; Ciudad A; Alvarez E; Bobes J; Gilaberte I
Eur Psychiatry; 2007 Nov; 22(8):490-8. PubMed ID: 17904337
[TBL] [Abstract][Full Text] [Related]
8. The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia.
Valencia M; Fresan A; Juárez F; Escamilla R; Saracco R
J Psychiatr Res; 2013 Dec; 47(12):1886-92. PubMed ID: 24112947
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
Novick D; Haro JM; Suarez D; Lambert M; Lépine JP; Naber D
Psychopharmacology (Berl); 2007 May; 191(4):1015-22. PubMed ID: 17310386
[TBL] [Abstract][Full Text] [Related]
10. An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case-control study.
Chou YH; Chiu NM; Yang TT; Feng J; Chan CC; Lee HK;
Int Clin Psychopharmacol; 2013 Sep; 28(5):255-60. PubMed ID: 23820333
[TBL] [Abstract][Full Text] [Related]
11. Remission after first-episode schizophrenia: results of a long-term follow-up.
Üçok A; Serbest S; Kandemir PE
Psychiatry Res; 2011 Aug; 189(1):33-7. PubMed ID: 21196051
[TBL] [Abstract][Full Text] [Related]
12. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
[TBL] [Abstract][Full Text] [Related]
13. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
Schennach-Wolff R; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Huff W; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Möller HJ; Riedel M
Schizophr Res; 2009 Sep; 113(2-3):210-7. PubMed ID: 19560901
[TBL] [Abstract][Full Text] [Related]
14. Clinical recovery in first-episode psychosis.
Wunderink L; Sytema S; Nienhuis FJ; Wiersma D
Schizophr Bull; 2009 Mar; 35(2):362-9. PubMed ID: 18990715
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?
Pinna F; Sanna L; Perra V; Pisu Randaccio R; Diana E; Carpiniello B;
Riv Psichiatr; 2014; 49(1):41-9. PubMed ID: 24572583
[TBL] [Abstract][Full Text] [Related]
16. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
El Gharbi I; Chhoumi M; Mechri A
Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
[TBL] [Abstract][Full Text] [Related]
17. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study.
Chang WC; Hui CL; Tang JY; Wong GH; Chan SK; Lee EH; Chen EY
Psychol Med; 2013 Sep; 43(9):1883-93. PubMed ID: 23217676
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of functional remission in schizophrenic disorder. The FROGS Scale].
Rouillon F; Baylé FJ; Gorwood P; Lancrenon S; Lançon C; Llorca PM;
Encephale; 2013 May; 39 Suppl 1():S15-21. PubMed ID: 23541143
[TBL] [Abstract][Full Text] [Related]
20. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.
Lambert M; Naber D; Schacht A; Wagner T; Hundemer HP; Karow A; Huber CG; Suarez D; Haro JM; Novick D; Dittmann RW; Schimmelmann BG
Acta Psychiatr Scand; 2008 Sep; 118(3):220-9. PubMed ID: 18699954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
